Hyperbaric Oxygen Therapy in Covid-19 Treatment: Efficacy and Safety-Reference-Cited by-同舟云学术

Hyperbaric Oxygen Therapy in Covid-19 Treatment: Efficacy and Safety

Published:2021-06-01 Issue:2 Volume:75 Page:25-40
ISSN:2084-0535
Container-title:Polish Hyperbaric Research
language:en
Short-container-title:

Author:

Ubysz Dorota¹,Giermaziak Wojciech¹,Ostrowska Aurelia²

Affiliation:

1. Main Medical Library in Warsaw , Poland

2. Military Medical Service Department in Warsaw , Poland

Abstract

Abstract Introduction: New effective treatments are sought to eliminate COVID-19-related hypoxia. Hyperbaric oxygen therapy is an effective method in the treatment of many diseases accompanied by hypoxia. Aim: The aim of this study was to analyse the literature on the use of hyperbaric oxygen in the treatment of COVID-19 and to evaluate the effectiveness and safety of this method. Materials and methods: Medical databases (Medline and PBL) and websites were reviewed using the terms hyperbaric oxygen and COVID-19. 25 works were qualified for the analysis. Conclusions: The analysed literature shows that hyperbaric oxygen therapy is an effective and safe method of treating patients with COVID-19. Due to the limited amount of scientific evidence assessing the use of HBOT in COVID-19, there is a need for further research to confirm the effectiveness and safety of this method.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Link

https://www.sciendo.com/pdf/10.2478/phr-2021-0009

Reference25 articles.

1. 1. Płusa Tadeusz, Baranowski Paweł. Tlenoterapia w niewydolności oddechowej. Intern. Rev. Med. Pract. 2021: 27 (2): 70-76;

2. 2. Oliaei Shahram, SeyedAlinaghi SeyedAhmad, Mehrtak Mohammad, Karimi Amirali, Noori Tayebeh, Mirzapour Pegah, Shojaei Alireza, MohsseniPour Mehrzad, Mirghaderi Seyed Peyman, Alilou Sanam, Shobeiri Parnian, Cheshmekabodi Hadiseh Azadi, Mehraeen Esmaeil, Dadras Omid: The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.. Eur J Med Res. 2021; 26(96): 1-12;10.1186/s40001-021-00570-2837442034412709

3. 3. Criado Paulo Ricardo, Miot Hélio Amante, Pincelli Thais Prota Hussein, Fabro Alexandre Todorovic: From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatologic Therapy. 2021; 34: e14565;10.1111/dth.14565774483233219572

4. 4. Ortega Miguel A., Martinez Oscar Fraile, García-Montero Cielo, Callejón-Peláez Enrique, Sáez Miguel A., Álvarez-Mon Miguel A., García-Honduvilla Natalio, Monserrat Jorg, Álvarez-Mon Melchor, Bujan Julia, Canals María Luisa: A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina 2021, 57, 864;10.3390/medicina57090864846592134577787

5. 5. Boet S, Etherington C, Djaiani G, Tricco AC, Sikora L, Katznelson R: Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review. Diving & Hyperbaric Medicine. 2021; 51(3): 271-281;10.28920/dhm51.3.271-281860844834547778